Boutique private markets advisor specializing in growth-stage and lower-middle-market equity and credit investments, Kings Path Partners LLC provides deal sourcing, capital placement and portfolio advisory for institutional and family-office clients. The firm positions itself as a sector-agnostic partner with emphasis on operational due diligence, co-investment facilitation and bespoke fund structuring to support scalable operating companies and sponsor-led transactions.
Boutique private markets advisor specializing in growth-stage and lower-middle-market equity and credit investments, Kings Path Partners LLC provides deal sourcing, capital placement and portfolio advisory for institutional and family-office clients. The firm positions itself as a sector-agnostic partner with emphasis on operational due diligence, co-investment facilitation and bespoke fund structuring to support scalable operating companies and sponsor-led transactions.
A boutique private‑markets advisor seeks to deploy patient, concentrated private‑markets capital into growth-stage and lower‑middle‑market companies via direct equity, credit and co‑investment structures. Emphasis is on sector‑agnostic underwriting informed by rigorous operational due diligence, alignment-focused co-investments, and bespoke fund structuring to preserve upside while controlling downside. Strategy favors partnership with founders and sponsors, active portfolio advisory to accelerate scaling, and a multi-year horizon with disciplined risk controls and capital‑efficient value creation.
A boutique private‑markets advisor seeks to deploy patient, concentrated private‑markets capital into growth-stage and lower‑middle‑market companies via direct equity, credit and co‑investment structures. Emphasis is on sector‑agnostic underwriting informed by rigorous operational due diligence, alignment-focused co-investments, and bespoke fund structuring to preserve upside while controlling downside. Strategy favors partnership with founders and sponsors, active portfolio advisory to accelerate scaling, and a multi-year horizon with disciplined risk controls and capital‑efficient value creation.
| Trades 1342 | Longs Won 819/1342 61% | Profit Factor 5.05 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $328,466.43 |
| Average Win $86,457.03 | Best Trade (Oct 15) $7.02M | Sharpe Ratio -10.59 |
| Average Loss -$26,834.96 | Worst Trade (Mar 30) -$668,915 | Z-Score 1.96 (95%) |
| Commissions $0 | Avg. Trade Length 1y 1m 2d | Expectancy $42,305.23 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 13,889 | 12,500 | 11,111 | 9,722 | 8,333 | 6,944 | 5,556 | 4,167 | 2,778 | 1,389 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2,121 | $495,684.78 | $730,302.72 | - | $234,617.94 | 47.33% | +0.678% |
ACWI iShares MSCI ACWI ETF | 5,085 | $719,477 | $804,930.07 | - | $85,453.07 | 11.88% | -0.587% |
ADMA Adma Biologics Inc. | 28,940 | $561,920.05 | $307,198.1 | - | -$254,721.95 | -45.33% | -1.072% |
AEM Agnico Eagle Mines Limited | 6 | $931 | $1,126.62 | - | $195.62 | 21.01% | +0.112% |
AGG iShares Core U.S. Aggregate Bond ETF | 2,372 | $231,344.73 | $225,944.86 | - | -$5,399.87 | -2.33% | -0.162% |
AGQ ProShares Ultra Silver | 12 | $537.86 | $713.55 | - | $175.69 | 32.66% | -0.929% |
AGX Argan Inc. | 713 | $201,978.46 | $253,107.87 | - | $51,129.41 | 25.31% | -3.315% |
ALL Allstate Corporation | 11 | $2,361 | $2,669.15 | - | $308.15 | 13.05% | +1.273% |
AMGN Amgen Inc. | 3 | $1,086 | $1,304.49 | - | $218.49 | 20.12% | +0.184% |
AMSC American Superconductor Corporation | 7,625 | $316,514 | $200,766.25 | - | -$115,747.75 | -36.57% | -2.083% |
AMT American Tower Corporation | 259 | $50,344 | $47,591.25 | - | -$2,752.75 | -5.47% | +1.318% |
AMZN Amazon.com Inc | 965 | $188,266.85 | $242,634.77 | - | $54,367.92 | 28.88% | -1.305% |
AMZY YieldMax AMZN Option Income Strategy ETF | 1,000 | $10,680 | $10,165 | - | -$515 | -4.82% | -1.311% |
ANGL VanEck Fallen Angel High Yield Bond ETF | 66 | $1,930 | $1,807.41 | - | -$122.59 | -6.35% | -0.309% |
ANGX Angel Studios, Inc. | 262 | $1,224 | $892.11 | - | -$331.89 | -27.12% | -7.473% |
ANIP Ani Pharmaceuticals Inc. | 6,200 | $397,441.43 | $446,803 | - | $49,361.57 | 12.42% | -0.297% |
ARKK ARK Innovation ETF Fund | 216 | $10,266.65 | $17,843.76 | - | $7,577.11 | 73.8% | -3.594% |
AVDE Avantis International Equity ETF | 862 | $68,343.59 | $77,700.68 | - | $9,357.09 | 13.69% | +0.278% |
AVDV Avantis International Small Cap Value ETF | 68,691 | $4.98M | $7.39M | - | $2.41M | 48.35% | +0.284% |
AVEM Avantis Emerging Markets Equity ETF | 88,015 | $6M | $7.85M | - | $1.85M | 30.79% | -1.289% |